MRK
Merck & Co., Inc.
—
113.87 $
-1.5700 (%-1.36)
Previous Close: 115.44
Day Low₺111.57
Day High₺114.94
MRK: Merck & Co., Inc. Financials
MRK Income Statement
Total revenue
Net income
Gross margin TTM
71.98%
Operating margin TTM
36.17%
Net profit margin TTM
28.12%
Return on investment TTM
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 64,926,000,000 | 64,168,000,000 | 60,115,000,000 | 59,283,000,000 |
| Operating income | 23,486,000,000 | 20,221,000,000 | 2,954,000,000 | 18,282,000,000 |
| Net income | 18,254,000,000 | 17,117,000,000 | 365,000,000 | 14,519,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 64,926,000,000 | 64,168,000,000 | 60,115,000,000 | 59,283,000,000 |
| Cost of revenue | 18,195,000,000 | 15,193,000,000 | 16,126,000,000 | 17,411,000,000 |
| Gross profit | 46,731,000,000 | 48,975,000,000 | 43,989,000,000 | 41,872,000,000 |
| Research and development expenses | 12,514,000,000 | 17,938,000,000 | 30,531,000,000 | 13,548,000,000 |
| General and administrative expenses | 0 | 7,700,000,000 | 7,584,000,000 | 7,469,000,000 |
| Selling and marketing expenses | 0 | 2,400,000,000 | 2,300,000,000 | 2,200,000,000 |
| Selling, general and administrative expenses | 10,731,000,000 | 10,100,000,000 | 9,884,000,000 | 9,669,000,000 |
| Other expenses | 0 | 716,000,000 | 620,000,000 | 373,000,000 |
| Operating expenses | 23,245,000,000 | 28,754,000,000 | 41,035,000,000 | 23,590,000,000 |
| Cost and expenses | 41,440,000,000 | 43,947,000,000 | 57,161,000,000 | 41,001,000,000 |
| Net interest income | -1,014,000,000 | -856,000,000 | -781,000,000 | -805,000,000 |
| Interest income | 343,000,000 | 415,000,000 | 365,000,000 | 157,000,000 |
| Interest expense | 1,357,000,000 | 1,271,000,000 | 1,146,000,000 | 962,000,000 |
| Depreciation and amortization | 5,838,000,000 | 4,499,000,000 | 3,872,000,000 | 3,909,000,000 |
| EBITDA | 28,262,000,000 | 25,706,000,000 | 6,907,000,000 | 21,315,000,000 |
| EBIT | 22,424,000,000 | 21,207,000,000 | 3,035,000,000 | 17,406,000,000 |
| Non-operating income (excl. interest) | 1,062,000,000 | -986,000,000 | -81,000,000 | 876,000,000 |
| Operating income | 23,486,000,000 | 20,221,000,000 | 2,954,000,000 | 18,282,000,000 |
| Total other income/expenses (net) | -2,419,000,000 | -285,000,000 | -1,065,000,000 | -1,838,000,000 |
| Income before tax | 21,067,000,000 | 19,936,000,000 | 1,889,000,000 | 16,444,000,000 |
| Income tax expense | 2,804,000,000 | 2,803,000,000 | 1,512,000,000 | 1,918,000,000 |
| Net income from continuing operations | 18,263,000,000 | 17,133,000,000 | 377,000,000 | 14,526,000,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 18,254,000,000 | 17,117,000,000 | 365,000,000 | 14,519,000,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 18,254,000,000 | 17,117,000,000 | 365,000,000 | 14,519,000,000 |
| EPS | 7 | 7 | 0.14 | 6 |
| Diluted EPS | 7 | 7 | 0.14 | 6 |
| Weighted average shares outstanding | 2,502,000,000 | 2,532,000,000 | 2,607,143,000 | 2,532,000,000 |
| Weighted average diluted shares outstanding | 2,507,000,000 | 2,541,000,000 | 2,547,000,000 | 2,542,000,000 |